Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» liver cancer
liver cancer
AstraZeneca charts new course for Imfinzi in liver cancer, but FDA path remains uncertain
Fierce Pharma
Fri, 01/19/24 - 11:13 am
AstraZenca
liver cancer
Imfinzi
Medivir partners with world-leading liver cancer experts in new Scientific Advisory Council
BioSpace
Mon, 08/7/23 - 10:48 am
Medvir
liver cancer
AstraZeneca’s liver cancer treatment shows ‘continued survival benefit’ in phase 3 trial
Biopharma Reporter
Mon, 07/3/23 - 10:46 am
AstraZeneca
Imfinzi
liver cancer
clinical trials
Genentech reveals positive results from cancer combo therapy trial
Clinical Trials Arena
Mon, 04/17/23 - 11:24 am
Genentech
Tecentriq
Avastin
liver cancer
hepatocellular carcinoma
AACR: Patient deaths taint Roche's industry-first early-stage liver cancer readout for Tecentriq and Avastin
Fierce Pharma
Sun, 04/16/23 - 11:26 pm
Roche
AACR
liver cancer
patient deaths
Roche’s Tecentriq to be filed for early-stage liver cancer
Pharmaphorum
Thu, 01/19/23 - 09:41 am
Roche
Tecentriq
Avastin
clinical trials
liver cancer
J&J leads $85M investment in HistoSonics ahead of liver cancer device authorization
Medtech Dive
Wed, 12/14/22 - 10:41 am
JNJ
funding
venture capital
HistoSonics
liver cancer
Medtech
Edison
devices
JNJ Innovation
AstraZeneca gets first okay for CTLA4 drug tremelimumab
Pharmaphorum
Mon, 10/24/22 - 10:50 am
AstraZene3ca
tremelimumab
liver cancer
FDA
$2.4B BridgeBio/Helsinn Liver Cancer Deal Falls Apart
BioSpace
Thu, 10/13/22 - 11:53 pm
BridgeBio
Helsinn
liver cancer
Truseltiq
ESMO 2022 – the new liver cancer entrants line up
EP Vantage
Thu, 09/8/22 - 10:39 am
ESMO
liver cancer
Keytruda
tislelizumab
camrelizumab
Merck
BeiGene
Novartis
BeiGene and Novartis Make Late-Stage Progress against Liver Cancer
BioSpace
Tue, 08/9/22 - 12:14 pm
Novartis
BeiGene
hepatocellular carcinoma
liver cancer
clinical trials
Merck's Keytruda, on a losing streak, fails in once FDA-rejected liver cancer use and prostate cancer—again
Fierce Pharma
Wed, 08/3/22 - 09:15 pm
Merck
Keytruda
FDA
liver cancer
Lenvima
Here's What AstraZeneca's Recent FDA News Means for Shareholders
Motley Fool
Mon, 05/30/22 - 10:15 am
AstraZeneca
FDA
Imfinzi
tremelimumab
liver cancer
After 18 years in development, AstraZeneca’s CTLA-4 antibody gets the red carpet treatment at the FDA
Endpoints
Mon, 04/25/22 - 10:20 am
AstraZeneca
FDA
tremelimumab
liver cancer
priority review
Exelixis throws in the towel on early-stage liver cancer after final readout shows OS flop
Endpoints
Tue, 03/15/22 - 10:39 am
Exelixis
Cabometyx
liver cancer
clinical trials
ASCO-GI – immuno-oncology makes progress in liver cancer
EP Vantage
Fri, 01/21/22 - 10:37 am
AstraZeneca
Imfinizi
tremelimumab
ASCO-GI
liver cancer
Almost three years after whiffing in a confirmatory study, Merck touts new data for Keytruda in HCC
Endpoints
Wed, 01/19/22 - 10:59 am
Merck
Keytruda
liver cancer
HCC
AstraZeneca: Imfinzi Plus Tremelimumab Improves OS In Phase III Trial In Liver Cancer
NASDAQ
Fri, 10/15/21 - 11:03 am
AstraZeneca
liver cancer
clinical trials
Imfinzi
tremelimumab
Relay Therapeutics’ Liver Cancer Approach Paying Early Dividends
BioSpace
Sat, 10/9/21 - 11:07 pm
Relay Therapeutics
RLY-4008
intrahepatic cholangiocarcinoma
liver cancer
Merck touts a confirmatory Keytruda win for liver cancer as 'dangling' accelerated approval saga marches on
Endpoints
Mon, 09/27/21 - 10:48 am
Merck
Keytruda
clinical trials
liver cancer
Pages
1
2
3
4
5
next ›
last »